Ignite Creation Date:
2024-05-05 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00001189
Status:
COMPLETED
Last Update Posted:
2008-03-04
First Post:
1999-11-03
Brief Title:
The Treatment of Grade I Sarcomas and Benign Non-Metastasizing Highly Invasive Soft Tissue Tumors
Sponsor:
National Cancer Institute NCI
Organization:
National Institutes of Health Clinical Center CC
Study Overview
Official Title:
The Treatment of Grade I Sarcomas and Benign Non-Metastasizing Highly Invasive Soft Tissue Tumors
Status:
COMPLETED
Status Verified Date:
2000-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Patients with Grade I soft tissue sarcomas or benign non-metastasizing invasive soft tissue tumors will receive wide local excision and be prospectively randomized as to either receive or not receive radiation therapy
Detailed Description:
This is a randomized study Patients undergo surgical excision of all gross disease and then are randomized to Arm I or Arm II
Arm I Radiotherapy Involved-field irradiation
Arm II No further treatment
Arm I Radiotherapy Involved-field irradiation
Arm II No further treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 83-C-0227 | None | None | None |